112¦~12¤ë¥÷³Ì·s°T®§(¤½§i¡B¬F¥O«Å¾É¡BÃÄ«~¦^¦¬)
 

¦¬¤å¦r¸¹

¨Ó¤å¾÷Ãö

¨Ó¤å¤é´Á

¨Æ¥Ñ

1120974

½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p

112/12/01

¥»¸p­q©ó112¦~12¤ë8¤é(¬P´Á¤­)¡A°²¶°«ä¥_¬ì¤j·|ij¤¤¤ß·ç¯SÆUÁ|¿ì¡uÃÄ«~¬dÅçµn°O¼f¬dº[½u¤W¥Ó½Ð§@·~¥­¥x(ExPRESS)·~ªÌ»¡©ú·|¡v¡A½Ð¶Q·|Âા©ÒÄÝ·|­û¿ãÅD³ø¦W°Ñ¥[¡C

1120975

½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p

112/12/01

¦]À³¬y¦æ©Ê¯e¯f¥ÎÃĻݨD¡A½ÐÂા©ÒÄÝ·|­û¡A½T«OÃÄ«~í©w¨ÑÀ³¡A¸Ô¦p»¡©ú¬q¡A½Ð¬d·Ó¡C

1120977

½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p

112/11/28

¦³Ãö½Ã¥ÍºÖ§Q³¡­×¥¿¡uÂåÀø¾¹§÷³\¥iÃÒ®Öµo»Pµn¿ý¤Î¦~«×¥Ó³ø·Ç«h¡v³¡¤À±ø¤å¤Î²Ä¤­±øªþªí¤@¡B²Ä¤»±øªþªí¤G¡Bªþªí¤T¡A»s³y³\¥i½s¸¹¯Ç¬°³\¥iÃÒµn°O¨Æ¶µ¤§¬ÛÃö±¹¬I¡A½Ð¬d·Ó(¨ÃÂા©ÒÄÝ)¡C

1120980

½Ã¥ÍºÖ§Q³¡

112/12/04

¬°½T«O¥Á²³¥ÎÃĦw¥þ¡A½Ð¶Q¤½¥q¨Ì»¡©ú¬q¿ì²zGavreto® (pralsetinib)ÃÄ«~¤¤¤å¥é³æÅܧó¡A¸Ô¦p»¡©ú¬q¡A½Ð¬d·Ó¡C

1120981

½Ã¥ÍºÖ§Q³¡

112/12/08

¡u¤½§i§tnifedipine¦¨¤ÀÃÄ«~¤§Á{§É®Ä¯q¤Î­·ÀI¦Aµû¦ôµ²ªG¬ÛÃö¨Æ©y¡v·~¸g¥»³¡©ó112¦~12¤ë8¤é½Ã±Â­¹¦r²Ä1121412087¸¹¤½§iµo¥¬¡A½Ð¬d·ÓÂà¦æ¡C

1120982

½Ã¥ÍºÖ§Q³¡

112/12/08

¬°½T«O¥Á²³¥ÎÃĦw¥þ¡A½Ð¶Q¤½¥q¨Ì»¡©ú¬q¿ì²z§tnifedipine¦¨¤ÀÃÄ«~¤§¤¤¤å¥é³æÅܧó¡A¸Ô¦p»¡©ú¬q¡A½Ð¬d·Ó¡C

1120983

»O¥_¥«¬F©²½Ã¥Í§½

112/12/04

¦³Ãö½Ã¥ÍºÖ§Q³¡112¦~11¤ë28¤é½Ã±Â­¹¦r²Ä1129070778¸¹¤½§iµù¾P¥xÆW¿ÕµØªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡u¦w²ö¯kª`®g²G¾¯70²@§J/²@¤É¡]½Ã³¡µß¬Ì¿é¦r²Ä001127¸¹¡^¡vÃÄ«~³\¥iÃÒ¤@®×¡A½ÐÂા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1120986

½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p

112/12/04

¦³Ãö¶Q¤½¥q¥Ó½Ð½Õ¾ã¡u¨Ì¹Å­á´¹°®Àêª`®g¾¯50²@§J¡AXeravapowderforinjection50mg¡]½Ã³¡ÃÄ¿é¦r²Ä028576¸¹¡^¡vÃÄ«~¦w¥þ©Ê©w´Á³ø§i¤§¸ê®Æ»`¶°ºI¤î¤é(DLP)¤@®×¡A´_¦p»¡©ú¬q¡A½Ð¬d·Ó¡C

1120991

½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p

112/12/06

¦³Ãö¶Q¤½¥q¥Ó½Ð½Õ¾ã¡uµÎ°±´_½¤¦ç¿õ6²@§J¡ASOTYKTUfilm-coatedtablets6mg¡]½Ã³¡ÃÄ¿é¦r²Ä028554¸¹¡^¡vÃÄ«~¦w¥þ©Ê©w´Á³ø§i¤§¸ê®Æ»`¶°ºI¤î¤é(DLP)¤@®×¡A´_¦p»¡©ú¬q¡A½Ð¬d·Ó¡C

1120993

»O¥_¥«¬F©²½Ã¥Í§½

112/12/07

¦³Ãö½Ã¥ÍºÖ§Q³¡112¦~11¤ë28¤é½Ã±Â­¹¦r²Ä1129070779¸¹¤½§iµù¾P¥xÆW¿ÕµØªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡u¦w²ö¯kª`®g²G¾¯140²@§J/²@¤É¡]½Ã³¡µß¬Ì¿é¦r²Ä001128¸¹¡^¡vÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û°t¦X¦^¦¬¨Æ©y¡A½Ð¬d·Ó¡C

1120996

½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p

112/12/08

¯÷ÀË°e¡u·sÃļf¬d¦X§@¤è®×°Ýµª¶°¡v­×­qª©¤¤­^¤å¹ï·Ó1¥÷¡A½Ð¬d·Ó¨ÃÂા©ÒÄÝ·|­û¡C

1120997

½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p

112/12/08

°t¦X112¦~9¤ë21¤éFDAÃĦr²Ä1121410069¸¹¤½§i­×­q¡u¥ÍÅé¬Ûµ¥©Ê¸ÕÅ礧¨ü°U¬ã¨s¾÷ºcºÞ²z³W½d¡v¡A¥»¸p­×­q¡u¥ÍÅé¬Ûµ¥©Ê¸ÕÅçÁ{§É¸ÕÅç³õ©Ò¬d®Öªí¡v¡B¡u¥ÍÅé¬Ûµ¥©Ê¸ÕÅç¤ÀªR³õ©Ò¬d®Öªí¡v¤Î·s¼W¬d®Öªí¤§¡u¦Û¦æ¶ñ¼g½d¨Ò¤Î»¡©ú¡v¡C¦Û113¦~1¤ë1¤é°_¡A¨ü¥»¸p¶i¦æ¥ÍÅé¬Ûµ¥©Ê¸ÕÅç°õ¦æ¾÷ºc¬d®Ö®É¡AÀ³¨Ì·sª©¬d®Öªí¶ñ³ø(½Ð³w¦Ü¥»¸pºô¯¸>·~°È±M°Ï>ÃÄ«~>ÃÄ«~Á{§É¸ÕÅç(§tBA/BE¸ÕÅç)±M°Ï¤U¸ü¨Ï¥Î)¡A½ÐÂા©ÒÄÝ·|­û¤Î¬ÛÃö³æ¦ì¡A½Ð¬d·Ó¡C

1120998

»O¥_¥«¬F©²½Ã¥Í§½

112/12/08

¦³Ãö½Ã¥ÍºÖ§Q³¡¤½§iµù¾P¥xÆW¿ÕµØªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡u½Ã¥Ø©úÂI²´²G0.2%¡]½Ã¸pÃÄ¿é¦r²Ä024211¸¹¡^¡vÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û°t¦X¦^¦¬¨Æ©y¡A½Ð¬d·Ó¡C

1120999

½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p

112/12/11

¦³Ãö¶Q¤½¥q¥Ó½Ð½Õ¾ã¡u·ÀÅè½F­á´¹ª`®g¾¯5²@§J¡AMYLOTARG5mgpowderforconcentrateforsolutionforinfusion¡]½Ã³¡µß¬Ì¿é¦r²Ä001244¸¹¡^¡vÃÄ«~¦w¥þ©Ê©w´Á³ø§i¤§¸ê®Æ»`¶°ºI¤î¤é(DLP)¤@®×¡A´_¦p»¡©ú¬q¡A½Ð¬d·Ó¡C

1121001

½Ã¥ÍºÖ§Q³¡

112/12/11

¦³Ãö¤½§i­×¥¿½Ã¥ÍºÖ§Q³¡109¦~7¤ë23¤é½Ã±Â­¹¦r²Ä1091406292¸¹¤½§i¡u¤fªA©TÅé»s¾¯¤W¥««áÅܧó¡v¤§ªþ¥óªí®æ¡A¨Ã¦Û¤¤µØ¥Á°ê113¦~1¤ë1¤é¥Í®Ä¤@®×¡A·~¸g¥»³¡©ó112¦~12¤ë11¤é½Ã±Â­¹¦r²Ä1121412317¸¹¤½§i­×¥¿¡A½Ð¦Ü¥»³¡­¹«~ÃĪ«ºÞ²z¸pºô¯¸¡]http://www.fda.gov.tw/¡^¤§¡u¤½§i¸ê°T¡v¤U¸ü¡A½Ð¬d·Ó¨ÃÂા©ÒÄÝ¡C

1121002

»O¥_¥«¬F©²½Ã¥Í§½

112/12/11

¦³Ãö½Ã¥ÍºÖ§Q³¡12¦~12¤ë4¤é½Ã±Â­¹¦r²Ä1129072004¸¹¤½§iµù¾P»OÆWªü´µ¯S±¶§Q±dªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡u±d¨Ö²ï«ùÄò©ÊÃĮĽ¤¦ç¿õ5²@§J/1000²@§J¡v¡]½Ã¸pÃÄ¿é¦r²Ä025453¸¹¡^ÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1121003

»O¥_¥«¬F©²½Ã¥Í§½

112/12/11

¦³Ãö½Ã¥ÍºÖ§Q³¡112¦~12¤ë1¤é½Ã±Â­¹¦r²Ä1129071968¸¹¤½§iµù¾P»OÆWªü´µ¯S±¶§Q±dªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡u±d¨Ö²ï«ùÄò©ÊÃĮĽ¤¦ç¿õ2.5²@§J/1000²@§J¡v¡]½Ã¸pÃÄ¿é¦r²Ä025455¸¹¡^ÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1121004

½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p

112/12/12

¦³Ãö­×¥¿ÃÄ«~¥~²°¼ÐÅÒ¹q¤l¤Æ¼f¬d¬yµ{¡A½Ð¬d·Ó¨ÃÂા©ÒÄÝ·|­û¡C

1121009

½Ã¥ÍºÖ§Q³¡

112/12/13

¦³Ãö¤½§i­×¥¿¡u»Î±µ©Ê¸ÕÅç°ò·Ç-±µ¨ü°ê¥~Á{§É¼Æ¾Ú¤§±Ú¸s¦]¯À¦Ò¶q¡v¤Î¤½§i¡u»Î±µ©Ê¸ÕÅç°ò·Ç-±µ¨ü°ê¥~Á{§É¼Æ¾Ú¤§±Ú¸s¦]¯À¦Ò¶q°Ýµª¶°¡v¤@®×¡A·~©ó¥»³¡©ó112¦~12¤ë13¤é½Ã±Â­¹¦r²Ä1121413132¸¹¤½§iµo¥¬¡A½Ð¦Ü¥»³¡­¹«~ÃĪ«ºÞ²z¸pºô¯¸(ºô§}¡Ghttp://www.fda.gov.tw/)¤§¡u¤½§i¸ê°T¡v¤U¸ü¡A½Ð¬d·Ó¨ÃÂા©ÒÄÝ·|­û¡C

1121011

½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p

112/12/14

¦³Ãö¤½§i¡u¼Æ¦ì°·±d§Þ³NÀ³¥Î©óÃÄ«~Á{§É¸ÕÅç°õ¦æ»·ºÝ¼Æ¾Ú¦¬¶°«ü¤Þ¡v¤@®×¡A·~¸g¥»¸p©ó112¦~12¤ë14¤éFDAÃĦr²Ä1121413157¸¹¤½§iµo¥¬¡A½Ð¦Ü¥»¸pºô¯¸(http://www.fda.gov.tw/)¤§¡u¤½§i¸ê°T¡v¤Î¡uÃÄ«~²Õ·~°È±M°Ï>ÃÄ«~Á{§É¸ÕÅç(§tBA/BE¸ÕÅç)±M°Ï¡v¤U¸ü¡A½Ð¬d·Ó¨ÃÂા©ÒÄÝ·|­û¤Î¬ÛÃö³æ¦ì¡C

1121012

½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p

112/12/14

¦³Ãö¤½§i¡u¥Í²zÃİʾǤÀªR³ø§i«ü¤Þ¡v¤@®×¡A·~¸g¥»¸p©ó112¦~12¤ë14¤éFDAÃĦr²Ä1121413372¸¹¤½§iµo¥¬¡A½Ð¦Ü¥»¸pºô¯¸¡]http://www.fda.gov.tw/¡^¤§¡u¤½§i¸ê°T¡v¤U¸ü¡A½Ð¬d·Ó¨ÃÂા©ÒÄÝ·|­û¡C

1121013

»O¥_¥«¬F©²½Ã¥Í§½

112/12/14

¦³Ãö½Ã¥ÍºÖ§Q³¡¤½§iµù¾P·Å¤h¹yÂåÃĪѥ÷¦³­­¤½¥q«ù¦³¤§¡u"·Å¤h¹y"¼Ö¯×²M¿õ20²@§J(¼Ö¥Ë¥q¥L¥Å)¡]½Ã¸pÃÄ»s¦r²Ä042627¸¹¡^¡vÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1121014

»O¥_¥«¬F©²½Ã¥Í§½

112/12/15

¦³Ãö½Ã¥ÍºÖ§Q³¡¤½§iµù¾P¸Û«~¶T©öªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡uÆQ»Ä¥ì´¶©Ô¨¯¶©¡v(½Ã¸pÃij°¿é¦r²Ä000578¸¹)ÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1121015

ªF§d¤j¾Ç

112/12/15

ÀË°e¥»®Õ113¾Ç¦~«×°Ó¾Ç°|EMBA°ª¶¥¸gÀçºÓ¤h¦b¾±M¯Z©Û¥Í¸ê°T¡A·q½Ð´f¤©¤½§i©Pª¾¨Ã¹ªÀy©ÒÄݦP¤¯¿ãÅD³ø¦Ò¡A½Ð¬d·Ó¡C

1121018

¹A·~³¡°Ê´Óª«¨¾¬ÌÀˬ̸p

112/12/18

¡u¤H¥ÎÃÄ«~¥Î©ó¤ü¿ß¤Î«D¸gÀٰʪ«¤§¨Ï¥ÎºÞ²z¿ìªk¡vµo¥¬«e»¡©ú·|ij

1121020

»O¥_¥«¬F©²½Ã¥Í§½

112/12/18

¦³Ãö½Ã¥ÍºÖ§Q³¡112¦~12¤ë11¤é½Ã±Â­¹¦r²Ä1129072002¸¹¤½§iµù¾P»OÆWªü´µ¯S±¶§Q±dªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡u±d¨Ö²ï«ùÄò©ÊÃĮĽ¤¦ç¿õ5²@§J/500²@§J¡v¡]½Ã¸pÃÄ¿é¦r²Ä025454¸¹¡^ÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1121021

²H¦¿¤j¾Ç¾Ç®Õ°]¹Îªk¤H²H¦¿¤j¾Ç

112/12/18

ÀË°e¥»®Õ¥ø·~ºÞ²z¾Ç¨t113¾Ç¦~«×ºÓ¤h¦b¾±M¯Z©Û¥Í®ü³ø¤Î©Û¥Í¸ê°T¡A½Ð´f¤©¤½§i©Pª¾¨Ã¹ªÀy¶Q³æ¦ì¦P¤¯¿ãÅD³ø¦W¡A½Ð¬d·Ó¡C

1121024

»O¥_¥«¬F©²½Ã¥Í§½

112/12/19

¦³Ãö½Ã¥ÍºÖ§Q³¡¤½§iµù¾P·Å¤h¹yÂåÃĪѥ÷¦³­­¤½¥q«ù¦³¤§¡u"·Å¤h¹y"²öµhª¢¸z·»·L²É½¦Ån50²@§J(¤G§J´â§h¶u)¡]½Ã¸pÃÄ»s¦r²Ä042588¸¹¡^¡vÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1121025

»O¥_¥«¬F©²½Ã¥Í§½

112/12/19

¦³Ãö½Ã¥ÍºÖ§Q³¡112¦~12¤ë12¤é½Ã±Â­¹¦r²Ä1129074768¸¹¤½§iµù¾P¥xÆW¿Õ©M¿Õ¼wÃÄ«~ªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡u¿Õ¯ØºÖª`®g¾¯¡v¡]½Ã³¡µß¬Ì¿é¦r²Ä001192¸¹¡^ÃÄ«~³\¥iÃÒ¤@®×¡A½ÐÂા©ÒÄÝ·|­û°t¦X¬ÛÃö¦^¦¬¨Æ©y¡A½Ð¬d·Ó¡C

1121027

»O¥_¥«¬F©²½Ã¥Í§½

112/12/21

¦³Ãö½Ã¥ÍºÖ§Q³¡¤½§iµù¾P¤¤¤Æ¦X¦¨¥Í§ÞªÑ¥÷¦³­­¤½¥q¤s¨Î¤u¼t«ù¦³¤§¡uÅð×ô»Ä¶Üú¿¤Aà­¡]½Ã¸pÃÄ»s¦r²Ä048247¸¹¡^¡vÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1121029

»O¥_¥«¬F©²½Ã¥Í§½

112/12/22

¦³Ãö¥Ã³ÓÃÄ«~¤u·~ªÑ¥÷¦³­­¤½¥q¦^¦¬¡u¦wÅ𶩿ˤô©Ê¨Å»I(½Ã¸pÃÄ»s¦r²Ä034821¸¹)¡v¡]§å¸¹P0102801¡BP0303302¡BP0605603¡BP0605704¡BP1002705¡BH0206501¡^ÃÄ«~¤@®×¡A½Ð¨ó§UÂા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1121030

½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p

112/12/22

½Ð¶Q¤½¥q¨ÌÃÄ«~¦w¥þºÊµøºÞ²z¿ìªk³W©wú¥æ¡u°ªºÝ¥|»ù¬y·P¬Ì­]¡AMVCFLUQuadrivalentpre-filledsyringeinjection¡]½Ã³¡µß¬Ì»s¦r²Ä000151¸¹¡^¡vÃÄ«~¦w¥þ©Ê©w´Á³ø§i¤ÎÃÄ«~¦w¥þ©ÊÁ`µ²³ø§i¡A¸Ô¦p»¡©ú¬q¡A½Ð¬d·Ó¡C

1121032

ªÀ¹Îªk¤H»OÆWÁ{§ÉÃľǷ|

112/12/25

¨Ì¾Ú½Ã¥ÍºÖ§Q³¡¡uÂå¨Æ¤H­û°õ·~µn°O¤ÎÄ~Äò±Ð¨|¿ìªk¡v¡]¤UºÙ¥»¿ìªk¡^¡A¥»·|¼W¦CÃĨƤH­ûÄ~Äò±Ð¨|½]®Ö§@·~¿ìªk¡A§Y¤é°_¹ê¬I¡A½Ð¨Ì»¡©ú¬q¥|¿ì²z¡A·q½Ð¡@¬d·Ó¡C

1121038

»O¥_¥«¬F©²½Ã¥Í§½

112/12/25

¦³Ãö½Ã¥ÍºÖ§Q³¡¤½§iµù¾P¥ÃÂפƾǤu·~ªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡u¥ÃºÖ1¸¹ª`®g²G¡]½Ã¸pÃÄ»s¦r²Ä039251¸¹¡^¡vÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1121039

»O¥_¥«¬F©²½Ã¥Í§½

112/12/25

¦³Ãö½Ã¥ÍºÖ§Q³¡¤½§iµù¾P¥ÃÂפƾǤu·~ªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡uÂ׬ü¥LªLª`®g²G¡]½Ã¸pÃÄ»s¦r²Ä058003¸¹¡^¡vÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1121040

»O¥_¥«¬F©²½Ã¥Í§½

112/12/25

¦³Ãö½Ã¥ÍºÖ§Q³¡¤½§iµù¾P¥ÃÂפƾǤu·~ªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡u¥ÃºÖ2¸¹ª`®g²G"¥ÃÂ×"¡]½Ã¸pÃÄ»s¦r²Ä036984¸¹¡^¡vÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1121041

»O¥_¥«¬F©²½Ã¥Í§½

112/12/25

¦³Ãö½Ã¥ÍºÖ§Q³¡¤½§iµù¾P±j¥Í¤Æ¾Ç»sÃļtªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡u"±j¥Í"§íµh¿õ¡]¤º½ÃÃÄ»s¦r²Ä003675¸¹¡^¡vÃÄ«~³\¥iÃÒ¤@®×¡A½Ð¶Q·|Âા©ÒÄÝ·|­û¡A½Ð¬d·Ó¡C

1121044

»O¥_¥«¬F©²½Ã¥Í§½

112/12/29

¦³Ãö½Ã¥ÍºÖ§Q³¡112¦~11¤ë17¤é½Ã±Â­¹¦r²Ä1129067070¸¹¤½§iµù¾P¿«¥i°ê»ÚªÑ¥÷¦³­­¤½¥q«ù¦³¤§¡u¬ü­}©w¥~¥Î·»²G¡v¡]½Ã¸pÃÄ»s¦r²Ä057346¸¹¡^ÃÄ«~³\¥iÃÒ¤@®×¡A½ÐÂા©ÒÄÝ·|­û°t¦X¬ÛÃö¦^¦¬¨Æ©y¡A½Ð¬d·Ó¡C

1121045

»O¥_¥«¬F©²³Ò°Ê§½

112/12/22

¥»§½­q©ó113¦~1¤ë30¤é¤Î2¤ë27¤é°w¹ï·s³]¥ß¤½¥q°Ó¸¹¡A¶}¿ì¡u³Ò°Ê°ò·Çªk¤Jªù¯Z¡v¡A´f½Ð¶Q³æ¦ì¿ãÅD³ø¦W°Ñ¥[¡A½Ð¬d·Ó¡C

¡@

¡@

¡@

¡@

¡@

¡@

ºô­¶³]­p